Minimally Invasive Device Market to Experience Growth

The worldwide market for minimally invasive surgery (MIS) devices is poised for expansion. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

MIS, which can be performed on both an inpatient and outpatient basis, appeals to patients because it means less blood loss, smaller surgical scars, shorter hospital stays, and fewer pain medications. Additional incentives involve payer programs that focus on prevention. A typical MIS procedure is performed through small incisions using specialized instruments, miniature cameras and fiber-optic light sources, and high definition (HD) monitors. In most cases, incisions are up to 10 cm in length, instead of the 15–20 cm incision required by traditional surgery.

The most common MIS procedure is small and large intestine endoscopy, which may or may not include biopsy. Gastrointestinal system MIS procedures supersede any other segment, with approximately 12 million surgeries performed in the United States alone; surgery involving the orthopedic system is another growth area for MIS techniques and equipment, with 40%–50% of knee surgeries in the United States and developed regions in Europe performed using MIS. Inguinal herniorrhaphy surgery follows with several million performed annually.

“The minimally invasive surgery devices market is well positioned for growth in the next five years,” said Kalorama analyst and report author Mary Ann Crandall. “Advances in technology, biologics, stem cell research, and regenerative medicine will help to expand opportunities of MIS. A concentration on earlier intervention for the prevention of disease will also stimulate the MIS market.”

According to Kalorama Information, the worldwide market for devices used in MIS procedures has experienced a number of technological advances over the years, providing surgeons with clinical options, which were previously only available as an invasive procedure. The market was valued at USD 27 billion in 2012, representing a 5.4% increase over 2010 figures.

Related Links:
Kalorama Information